- 152.7k views
Bronchial Asthma: Management
The management of bronchial asthma focuses on controlling and alleviating symptoms to improve a patient's quality of life. This involves two key components: long-term control and quick-relief (rescue) medications. Long-term control medications, often in the form of inhaled corticosteroids or leukotriene modifiers, are used to reduce airway inflammation and prevent asthma symptoms. Quick-relief medications, such as short-acting beta-agonists, provide immediate relief during asthma attacks. Patients also benefit from creating an asthma action plan, which includes monitoring symptoms, recognizing triggers, and knowing when to seek medical help. A collaborative approach between healthcare providers and patients is essential in tailoring the treatment plan to individual needs and ensuring optimal asthma management.
About the Speaker
Dr. Prashant Saxena
Associate Director & Head, Pulmonology, Critical Care & Sleep Medicine, Fortis Hospital
Dr. Prashant holds clinical expertise in the managing critically ill patients and various respiratory conditions. As a Chairperson of Cardiac Resuscitation Committee, he has introduced the concept of Rapid Response Team for patients in order to decrease the numbers of unexpected events in the hospital.
Upcoming Case Discussions
Preparing your Practice for Adoption of AI
Preparing Your Practice for Adoption of AI" involves building a foundation of digital literacy, data readiness, and ethical awareness among clinicians and staff. Successful integration starts with identifying key workflows where AI can enhance efficiency, accuracy, or patient outcomes. It’s essential to choose tools that align with your practice’s goals while ensuring transparency, security, and compliance. Training, change management, and continuous evaluation are critical to fostering trust and long-term adoption. Ultimately, AI should support—not replace—the human touch in medicine.
AI in Medicine: Challenges and Opportunities
AI in Medicine: Challenges and Opportunities explores the transformative potential of artificial intelligence in improving diagnostics, treatment planning, and healthcare delivery. The session highlights how AI can enhance clinical accuracy, streamline workflows, and support personalized medicine. At the same time, it addresses key challenges such as data privacy, algorithm bias, and the need for regulatory oversight. Real-world applications and case studies illustrate both the promise and the pitfalls of integrating AI into clinical practice. This session aims to equip healthcare professionals with a balanced view of how AI can complement human expertise in medicine.
Ayurvedic Path to Parkinson’s Relief: Research Based Perspective
Ayurvedic Path to Parkinson's Relief: A Research-Based Perspective explores how ancient Ayurvedic principles can complement modern approaches in managing Parkinson's disease. Drawing from recent clinical studies and traditional wisdom, this session delves into the use of herbal formulations, Panchakarma therapies, and lifestyle modifications to alleviate motor and non-motor symptoms. It highlights the neuroprotective potential of key herbs like Mucuna pruriens and Ashwagandha. Backed by evidence and expert insights, the session aims to bridge traditional healing with modern neurological care for holistic patient outcomes.
Congenital Uterine Anomalies
Congenital uterine anomalies are structural abnormalities of the uterus resulting from improper fusion, canalization, or resorption of the Müllerian ducts during fetal development. These anomalies include septate, bicornuate, unicornuate, and didelphys uterus, among others. They can be asymptomatic or associated with infertility, recurrent pregnancy loss, preterm birth, or abnormal menstruation. Diagnosis is typically made using imaging modalities like ultrasound, MRI, or hysterosalpingography. Treatment depends on the type and severity of the anomaly, with surgical correction such as hysteroscopic septum resection often indicated in symptomatic cases. Early detection is crucial for optimizing reproductive outcomes and guiding appropriate management strategies.
Approach to severe hyperkalemia in ICU
Approach to Severe Hyperkalemia in the ICU focuses on rapid identification and targeted intervention to prevent life-threatening complications. The session outlines key steps including ECG monitoring, membrane stabilization with calcium gluconate, intracellular potassium shift using insulin-dextrose and beta-agonists, and potassium elimination via diuretics or dialysis. It emphasizes prioritizing reversible causes like renal failure or medication-induced hyperkalemia. Real-world ICU scenarios and evidence-based protocols will guide clinicians in managing this critical electrolyte emergency effectively.
Author Post
Impact
+
Talks
+
webinar
+
no.of registrations
One liner about speaker
Why is speaker relevant?
Dr. Prashant Saxena's Talks on Assimilate
- 27th-September-2023, TIME : 06:00PM - 07:00PM
- 0
The management of bronchial asthma focuses on controlling and alleviating symptoms to improve a patient's quality of life. This involves two key components: long-term control and quick-relief (rescue) medications. Long-term control medications, often in the form of inhaled corticosteroids or leukotriene modifiers, are used to reduce airway inflammation and prevent asthma symptoms. Quick-relief medications, such as short-acting beta-agonists, provide immediate relief during asthma attacks. Patients also benefit from creating an asthma action plan, which includes monitoring symptoms, recognizing triggers, and knowing when to seek medical help. A collaborative approach between healthcare providers and patients is essential in tailoring the treatment plan to individual needs and ensuring optimal asthma management.
- 27th-September-2023, TIME : 06:00PM - 07:00PM
- 0
The management of bronchial asthma focuses on controlling and alleviating symptoms to improve a patient's quality of life. This involves two key components: long-term control and quick-relief (rescue) medications. Long-term control medications, often in the form of inhaled corticosteroids or leukotriene modifiers, are used to reduce airway inflammation and prevent asthma symptoms. Quick-relief medications, such as short-acting beta-agonists, provide immediate relief during asthma attacks. Patients also benefit from creating an asthma action plan, which includes monitoring symptoms, recognizing triggers, and knowing when to seek medical help. A collaborative approach between healthcare providers and patients is essential in tailoring the treatment plan to individual needs and ensuring optimal asthma management.
- 27th-September-2023, TIME : 06:00PM - 07:00PM
- 0
The management of bronchial asthma focuses on controlling and alleviating symptoms to improve a patient's quality of life. This involves two key components: long-term control and quick-relief (rescue) medications. Long-term control medications, often in the form of inhaled corticosteroids or leukotriene modifiers, are used to reduce airway inflammation and prevent asthma symptoms. Quick-relief medications, such as short-acting beta-agonists, provide immediate relief during asthma attacks. Patients also benefit from creating an asthma action plan, which includes monitoring symptoms, recognizing triggers, and knowing when to seek medical help. A collaborative approach between healthcare providers and patients is essential in tailoring the treatment plan to individual needs and ensuring optimal asthma management.